公开(公告)号：EP4389130A1

公开(公告)日：2024-06-26

申请号：EP22857846.4

申请日：2022-08-17

申请人： Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. ,  Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.

发明人： WANG, Yandong ,  SU, Yingxue ,  CAO, Chen ,  WU, Meirong ,  XUE, Yaping ,  YU, Chuiliang

IPC分类号： A61K31/575 ,  A61P27/12

CPC分类号： A61K31/575 ,  A61P27/12

摘要： An application of a steroid compound in the preparation of a drug for preventing and/or treating eye floaters. The steroid compound can have good therapeutic, alleviative, and preventive effects on eye floaters, can alleviate and/or cure eye floaters to a great extent, and can improve visual clarity.

公开(公告)号：EP4389131A1

公开(公告)日：2024-06-26

申请号：EP22857847.2

申请日：2022-08-17

申请人： Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. ,  Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.

发明人： WANG, Yandong ,  SU, Yingxue ,  CAO, Chen ,  ZHOU, Sheng'an ,  XUE, Yaping ,  WU, Meirong ,  YU, Chuiliang

IPC分类号： A61K31/575 ,  A61K47/38 ,  A61K47/40 ,  A61K47/26 ,  A61K47/34 ,  A61K47/10 ,  A61K9/08 ,  A61K9/107 ,  A61K9/70 ,  A61P27/12 ,  A61P27/02

CPC分类号： A61K9/70 ,  A61K47/40 ,  A61K31/575 ,  A61K9/107 ,  A61P27/12 ,  A61K47/10 ,  A61K47/34 ,  A61K47/26 ,  A61K47/38 ,  A61P27/02 ,  A61K9/08

摘要： A pharmaceutical composition, a preparation method therefor and an application thereof. The pharmaceutical composition comprises the following components : a compound represented by formula I, hydroxypropyl methyl cellulose, benzalkonium chloride, and a pH regulator. The pharmaceutical composition can be used for preparing drugs for preventing or treating cataracts. The pharmaceutical composition has excellent stability in respect of exposure to light and to high temperatures, can be stored at room temperature, is convenient for patients to use, has pH and osmotic pressure close to those in the intraocular environment, is uniform in particle size distribution, and thus can give the patients good comfort.